Kenji Oritani

7.7k total citations · 1 hit paper
177 papers, 6.3k citations indexed

About

Kenji Oritani is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kenji Oritani has authored 177 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Immunology, 59 papers in Molecular Biology and 50 papers in Oncology. Recurrent topics in Kenji Oritani's work include Cell Adhesion Molecules Research (42 papers), Cytokine Signaling Pathways and Interactions (34 papers) and Immune Cell Function and Interaction (25 papers). Kenji Oritani is often cited by papers focused on Cell Adhesion Molecules Research (42 papers), Cytokine Signaling Pathways and Interactions (34 papers) and Immune Cell Function and Interaction (25 papers). Kenji Oritani collaborates with scholars based in Japan, United States and Germany. Kenji Oritani's co-authors include Yoshiaki Tomiyama, Yūji Matsuzawa, Takafumi Yokota, Jun Ishikawa, Tadashi Matsuda, Yuzuru Kanakura, Paul W. Kincade, Ryuta Muromoto, Tohru Funahashi and Isao Takahashi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Kenji Oritani

169 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

2000 1.1k citations Takafumi Yokota, Kenji Oritani et al. profile →

Peers

Countries citing papers authored by Kenji Oritani

Since Specialization

Citations

This map shows the geographic impact of Kenji Oritani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Oritani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Oritani more than expected).

Fields of papers citing papers by Kenji Oritani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Oritani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Oritani. The network helps show where Kenji Oritani may publish in the future.

Co-authorship network of co-authors of Kenji Oritani

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Oritani. A scholar is included among the top collaborators of Kenji Oritani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Oritani. Kenji Oritani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STAP-2 Is a Novel Positive Regulator of TCR-Proximal Signals 2022 ·The Journal of Immunology ·(unknown), Jun‐ichi Kashiwakura, (unknown), (unknown), (unknown), Yuichi Sekine, Yuichi Kitai, Ryuta Muromoto, Michiko Ichii, Hiroko Nakatsukasa, Akihiko Yoshimura, Kenji Oritani, Tadashi Matsuda	8
2	Current understanding of the role of tyrosine kinase 2 signaling in immune responses 2022 ·World Journal of Biological Chemistry ·Ryuta Muromoto, Kenji Oritani, Tadashi Matsuda	32
3	Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival 2021 ·Biochemical and Biophysical Research Communications ·(unknown), Yuichi Kitai, Jun‐ichi Kashiwakura, Ryuta Muromoto, (unknown), Michiko Ichii, Kenji Oritani, Tadashi Matsuda	8
4	The mechanism of Tyk2 deficiency-induced immunosuppression in mice involves robust IL-10 production in macrophages 2020 ·Cytokine ·(unknown), Ryuta Muromoto, (unknown), Tomohiro Matsumoto, Yuichi Kitai, Jun‐ichi Kashiwakura, Kazuya Shimoda, Kenji Oritani, Tadashi Matsuda	10
5	Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function 2020 ·Leukemia ·(unknown), Sachiko Ezoe, Jiro Fujita, Daisuke Okuzaki, Daisuke Motooka, Tomohiko Ishibashi, Michiko Ichii, Akira Tanimura, Masako Kurashige, Eiichi Morii, Takuya Fukushima, Youko Suehiro, Takafumi Yokota, Hirohiko Shibayama, Kenji Oritani, Yuzuru Kanakura	25
6	Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V 2020 ·Nature Communications ·Shinya Rai, Hirokazu Tanaka, Mai Suzuki, J. Luis Espinoza, (unknown), Akira Tanimura, Takafumi Yokota, Kenji Oritani, Toshio Watanabe, Yuzuru Kanakura, Itaru Matsumura	20
7	Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML 2020 ·Oncogene ·(unknown), Michiko Ichii, Kenji Oritani, Hirohiko Shibayama, Akira Tanimura, Hideaki Saito, Takafumi Yokota, Daisuke Motooka, Daisuke Okuzaki, Yuichi Kitai, Ryuta Muromoto, Jun‐ichi Kashiwakura, Tadashi Matsuda, Naoki Hosen, Yuzuru Kanakura	13
8	IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization 2019 ·ImmunoHorizons ·Ryuta Muromoto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuichi Kitai, Jun‐ichi Kashiwakura, Kazuya Shimoda, Kenji Oritani, Tadashi Matsuda	18
9	BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21CIP1/WAF1 2010 ·Journal of Biological Chemistry ·Masahiro Tokunaga, Sachiko Ezoe, Hirokazu Tanaka, Yusuke Satoh, Kentaro Fukushima, (unknown), Masaru Shibata, Akira Tanimura, Kenji Oritani, Itaru Matsumura, Yuzuru Kanakura	16
10	Signal-Transducing Adaptor Protein-2 Regulates Stromal Cell-Derived Factor-1α-Induced Chemotaxis in T Cells 2009 ·The Journal of Immunology ·Yuichi Sekine, Osamu Ikeda, Satoshi Tsuji, Chikako Yamamoto, Ryuta Muromoto, Asuka Nanbo, Kenji Oritani, Akihiko Yoshimura, Tadashi Matsuda	33
11	Signal-Transducing Adaptor Protein-2 Regulates Integrin-Mediated T Cell Adhesion through Protein Degradation of Focal Adhesion Kinase 2007 ·The Journal of Immunology ·Yuichi Sekine, Satoshi Tsuji, Osamu Ikeda, (unknown), Kenji Oritani, Kazuya Shimoda, Ryuta Muromoto, Norihiko Ohbayashi, Akihiko Yoshimura, Tadashi Matsuda	53
12	Modulation of TLR4 Signaling by a Novel Adaptor Protein Signal-Transducing Adaptor Protein-2 in Macrophages 2006 ·The Journal of Immunology ·Yuichi Sekine, Taro Yumioka, Tetsuya Yamamoto, Ryuta Muromoto, Seiyu Imoto, (unknown), Kenji Oritani, Kazuya Shimoda, (unknown), Shizuo Akira, Akihiko Yoshimura, Tadashi Matsuda	83
13	Physical and Functional Interactions between Daxx and DNA Methyltransferase 1-Associated Protein, DMAP1 2004 ·The Journal of Immunology ·Ryuta Muromoto, Kenji Sugiyama, (unknown), Seiyu Imoto, Noriko Sato, Tetsuya Yamamoto, Kenji Oritani, Kazuya Shimoda, Tadashi Matsuda	73
14	Adiponectin, a Fat Cell Product, Influences the Earliest Lymphocyte Precursors in Bone Marrow Cultures by Activation of the Cyclooxygenase-Prostaglandin Pathway in Stromal Cells 2003 ·The Journal of Immunology ·Takafumi Yokota, C.S. Reddy Meka, Taku Kouro, Kay L. Medina, Hideya Igarashi, Masahiko Takahashi, Kenji Oritani, Tohru Funahashi, Yoshiaki Tomiyama, Yūji Matsuzawa, Paul W. Kincade	111
15	Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins 2002 ·Journal of Clinical Investigation ·Takafumi Yokota, C.S. Reddy Meka, Kay L. Medina, Hideya Igarashi, P C Comp, Masahiko Takahashi, Makoto Nishida, Kenji Oritani, Jun-ichiro Miyagawa, Tohru Funahashi, Yoshiaki Tomiyama, Yūji Matsuzawa, Paul W. Kincade	123
16	Cutting Edge: Tyk2 Is Required for the Induction and Nuclear Translocation of Daxx Which Regulates IFN-α-Induced Suppression of B Lymphocyte Formation 2002 ·The Journal of Immunology ·Kazuya Shimoda, (unknown), Akihiko Numata, Kenichi Aoki, Tadashi Matsuda, Kenji Oritani, Sadafumi Tamiya, Kouji Kato, Ken Takase, (unknown), Tetsuya Yamamoto, Toshihiro Miyamoto, Koji Nagafuji, Hisashi Gondo, Seiho Nagafuchi, Kei-ichi Nakayama, Mine Harada	52
17	Interaction Between Src Homology 2 Domain Bearing Protein Tyrosine Phosphatase Substrate-1 and CD47 Mediates the Adhesion of Human B Lymphocytes to Nonactivated Endothelial Cells 2002 ·The Journal of Immunology ·Hitoshi Yoshida, Yoshiaki Tomiyama, Kenji Oritani, Yoko Murayama, Jun Ishikawa, (unknown), Jun‐ichiro Miyagawa, Nakayuki Honma, Tetsuo Nishiura, Yūji Matsuzawa	27
18	A New IFN-Like Cytokine, Limitin Modulates the Immune Response Without Influencing Thymocyte Development 2001 ·The Journal of Immunology ·Isao Takahashi, Hiroshi Kosaka, Kenji Oritani, William R. Heath, Jun Ishikawa, Yu Okajima, Megumu Ogawa, (unknown), (unknown), Hiroaki Azukizawa, Satoshi Itami, Kunihiko Yoshikawa, Yoshiaki Tomiyama, Yūji Matsuzawa	12
19	Thrombopoietin-Induced Differentiation of a Human Megakaryoblastic Leukemia Cell Line, CMK, Involves Transcriptional Activation of p21 ^WAF1/Cip1 by STAT5 1997 ·Molecular and Cellular Biology ·Itaru Matsumura, Jun Ishikawa, Koichi Nakajima, Kenji Oritani, Yoshiaki Tomiyama, Jun-ichiro Miyagawa, Takashi Kato, Hiroshi Miyazaki, Yūji Matsuzawa, Yuzuru Kanakura	177
20	Glycosylation of CD44 negatively regulates its recognition of hyaluronan. 1995 ·The Journal of Experimental Medicine ·Shigeki Katoh, Ze‐Yi Zheng, Kenji Oritani, Takaichi Shimozato, P W Kincade	228

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact